Disseminated Intravascular Coagulation: A Review of Etiology,Pathophysiology,Diagnosis,and Management: Guidelines for Care

Abstract

References

1. Bick RL . Disseminated intravascular coagulation: Objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clin AppI Thromb Hemost 1995;1:3-3.

2. Baker WF . Clinical aspects of disseminated intravascular coagulation: A clinicians point of view. Semin Thromb Hemost 1989;15:1-1

3. Bick RL . Disseminated intravascular coagulation and related syndromes: A clinical review. Semin Thromb Hemost 1988;14:299-299.

4. Bick RL . Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment and assessment of therapeutic response. Semin Thromb Hemost 1996;22:69-69.

5. Bick RL , Baker WF . Disseminated intavascular coagulation. Hematol Pathol 1992;6: 1-1.

6. Baker WF . Clinical aspects of disseminated intravascular coagulation: A clinicians point of view. Semin Thromb Hemost 1989;15:1-1.

7. Bick RL . Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations. Semin Thromb Hemost 1998;24:3-3.

8. Bick RL . Disseminated intravascular coagulation: Objective Laboratory Diagnostic Criteria and Guidelines for Management. Clin Lab Med 1994;14:729-729.

9. Bick RL , Baker WF . Disseminated intavascular coagulation. Hematol Pathol 1992;6:1-1.

10.

10. Lasch HG , Henne DL , Huth K , Sandritter W . Pathophysiology clinical manifestations, and therapy of consumptive coagulopathy. Am J Cardiol 1967;20:381-381.

11.

11. Steiner PE , Lushbough CC . Maternal pulmonary embolism by amniotic fluid as a cause of shock and unexplained deaths in obstetrics. JAMA 1941;117:1245-1245.

12.

12. Graeff N , Kuhn W . The amniotic infection syndrome. In: Coagulation Disorders in Obstetrics. Philadelphia: WB Saunders, 1980:91-91.

13.

13. Sperry K . Amniotic fluid embolism: To understand an enigma. JAMA 1986;255:2183-2183.

14.

14. Locksmith GJ . Amniotic fluid embolism. Obstet Gynecol Clin North Am 1999;26:435-435.

15.

15. Nadesan K , Jayalakshmi P . Sudden maternal deaths from amniotic fluid embolism. Ceylon Med J 1997;42:185-185.

16.

16. Gilbert WM , Danielsen B . Amniotic fluid embolism: Decreased mortality in a population-based study. Obstet Gynecol 1999;93:973-973.

17.

17. Lamy C , Sharshar T , Mas JL . Cerebrovascular diseases in pregnancy and puerperium. Rev Neurol 1996;152:422-422.

18.

18. Mas JL , Lamy C . Stroke in pregnancy and the puerperium [review]. J Neurol 1998;245:305-305.

19.

19. Fiana S . Maternal mortality in Sweden: 1955-1974. Acta Obstet Gynecol Scand 1978;57:129-129.

20.

20. Peterson EP , Taylor HB . Amniotic fluid embolism: An analysis of 40 cases. Obstet Gynecol 1970;35:787-787.

21.

21. Aznar J , Gilabert J , Estelles A , et al. Evaluation of the soluble fibrin monomer complexes and other coagulation parameters in obstetric patients. Thromb Res 1982; 27:691-691.

22.

22. Minna JD , Robboy SJ , Coleman RW . Disseminated Intravascular Coagulation in Man. Springfield, IL: Charles C. Thomas, 1974:12-15,156-157.

23.

23. Aguillon A , Andrus T , Grayson A , Race GJ . Amniotic fluid embolism: A review. Obstet Gynecol Surv 1962;17:619-619.

24.

24. Cortney LD . Amniotic fluid embolism. Obstet Gynecol Surv 1974;29: 169-169.

25.

25. D'Addato F , Repinto A , Angeli G . Amniotic fluid embolism in trial of labor. A case report. Min Ginecol 1997;49:217-217.

26.

26. Judich A , Kuriansky J , Engelberg I , et al. Amniotic fluid embolism following blunt abdominal trauma in pregnancy. Injury 1998;29:475-475.

27.

27. Morgan M . Amniotic fluid embolism. Anesthesia 1979;34: 20-20.

28.

28. Price T , Baker W , Cefalo RL . Amniotic fluid embolism, three case reports with a review of the literature. Obstet Gynecol Surv 1985;40:462-462.

29.

29. Albrechtsen OK . Hemorrhagic disorders following amniotic fluid embolism. Clin Obstet Gynecol 1964;7:361-361.

30.

30. Russell WS , Jones WH . Amniotic fluid embolism: A review of the syndrome with a report of 4 cases. Obstet Gynecol 1965;26:476-476.

31.

31. Aznar J , Gilabert J , Estelles A , Parrilla JJ . Evaluation of plasminogen and other fibrinolytic parameters in the amniotic fluid [letter]. Thromb Hemost 1980;43:182-182.

32.

32. Beller FK , Douglas AW , Debrovnet CH , Robinson R . The fibrinolytic system in amniotic fluid embolism. Am J Obstet Gynecol 1963;87:48-48.

33.

33. Atwood HD . The histological diagnosis of amniotic fluid embolism. J Pathol Bact 1958;76:211-211.

34.

34. Yaffe H , Eldor A , Hornshtein E , Sadovsky E . Thromboplastic activity in amniotic fluid during pregnancy. Obstet Gynecol 1977;50:454-454.

35.

35. Yaffe H , Hay-am E , Sadovsky E . Thromboplastic activity of amniotic fluid in term and postmature gestations. Obstet Gynecol 1981;57:490-490.

36.

36. Liban E , Raz S . A clinicopathologic study of fourteen cases of amniotic fluid embolism. Am J Clin Pathol 1969;51: 477-477.

37.

37. Sparr RA , Prichard JA . Studies to detect the escape of amniotic fluid into the maternal circulation during parturition. Surg Gynecol Obstet 1958;107:560-560.

38.

38. Petroianu GA , Altmannsberger SH , Maleck WH , et al. Meconium and amniotic fluid embolism: Effects on coagulation in pregnant mini-pigs. Crit Care Med 1999;27: 348-348.

39.

39. Kobayashi H , Ooi H , Hayakawa H , et al. Histological diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc epitope. Hum Pathol 1997;28:428-428.

40.

40. Oi H , Kobayashi H , Hirashima Y , et al. Serological and immunohistochemical diagnosis of amniotic fluid embolism. Semin Thromb Hemost 1998;24:479-479.

41.

41. Lunetta P , Penttila A . Immunohistochemical identification of syncytiotrophoblastic cells and megakaryocytes in pulmonary vessels in a fatal case of amniotic fluid embolism. Int J Legal Med 1996;108:210-210.

42.

42. Bick RL . Disseminated intravascular coagulation: Objective criteria for diagnosis and management. Med Clin North Am 1994;78:511-511.

43.

43. Gross P , Benz EJ . Pulmonary embolism by amniotic fluid: Report of three cases with a new diagnostic procedure. Surg Gynecol Obstet 1947;85:315-315.

44.

44. Vedernikov YP , Saade GR , Zlatnik M , et al. The effect of amniotic fluid on the human omental artery in vitro. Am J Obstet Gynecol 1999; 180:454-454.

45.

45. Khong TY . Expression of endothelin-1 in amniotic fluid embolism and possible pathophysiological mechanism. Br J Obstet Gynaecol 1998;105:802-802.

46.

46. English CJ , Poller L , Burslem RW . A study of the procoagulant properties of amniotic fluid and their correlation with the lecithin/sphingomyelin ratio. Br J Obstet Gynecol 1981;88:133-133.

47.

47. Pusey ML , Mende TJ . Studies on the procoagulant activity of human amniotic fluid I. Stability and coagulation factor requirements. Thromb Res 1985;39:355-355.

48.

48. Pusey M , Mende TJ . Studies on the procoagulant activity of human anmniotic fluid II. The role of factor VII. Thromb Res 1985;39:571-571.

49.

49. Bick RL , Murano G . Physiology of hemostasis. Clin Lab Med 1994;14:677-677.

50.

50. Bussen S , Schwarzmann G , Steck T . Clinical aspects and therapy of amniotic fluid embolism. Illustration based on a case report. Zeitschr Geburt Neonatol 1997;201:95-95.

51.

51. Davies S . Amniotic fluid embolism and isolated disseminated intravascular coagulation. Can J Anaesth 1999; 46:456-456.

52.

52. Van Heerden PV , Webb SA , Hee G , et al. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia Anaesth Intensive Care 1996;24:87-87.

53.

53. Strickland MA , Bates AW , Whitworth HS , Martin JN . Amniotic fluid embolism: Prophylasix with heparin and aspirin. South Med J 1985;78:377-377.

54.

54. Bick RL , Fekete LF , Wilson WL . Treatment of disseminated intravascular coagulation with antithrombin III. Trans Am Soc Hematol 1976:167-167.

55.

55. Vinazzer H . Antithrombin III in shock and disseminated intravascular coagulation. Clin Appl Thromb Hemost 1995;1:62-62.

56.

56. Vinazzer H . Hereditary and acquired antithrombin deficiency. Semin Thromb Hemost 1999;25:257-257.

57.

57. Suzuki S , Morishita S . Hypercoagulability and DIC in high-risk infants. Semin Thromb Hemost 1998;24:463-463.

58.

58. Bick RL . Disseminated intravascular coagulation: Objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clin Appl Thromb Hemost 1995;1:3-3.

59.

59. Bick RL . Syndromes of disseminated intravascular coagulation. Chapter 2. In: Disseminated Intravascular Coagulation and Related Syndromes. Boca Raton, FL: CRC Press, 1982.

60.

60. Bick RL , Arun B , Frenkel EP . Disseminated intravascular coagulation: Clinical and pathophysiological mechanisms and manifestations. Haemostasis 1999;29:111-111.

61.

61. Bick RL . Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment and assessment of therapeutic response. Semin Thromb Hemost 1996;22:69-69.

62.

62. Hafter R , Graeff H . Molecular aspects of defibrination in a reptilase-treated case of “dead-fetus syndrome.” Thromb Res 1975;7:391-391.

63.

63. Steichele DF . Consumptive coagulopathy in obstetrics and gynecology. Thromb Diath Haemorrh (suppl) 1969;36:177-177.

64.

64. Brenner BM . Vascular injury to the kidney. In: Fauci AS , Braunwald E , Isselbacher KJ , et al, eds. Principles of Internal Medicine. Dubuque, IA: McGraw-Hill, 1998:1558-1558.

65.

65. Mjahed K , Hammamouchi B , Hammoudi D , et al. Critical analysis of hemostasis disorders in the course of eclampsia. Report of 106 cases. J Gynecol Obstet Biol Reprod 1998;27:607-607.

66.

66. Porozhanova V , Bozhinova S , Khristova V . The perinatal outcome in adolescents with eclampsia and the HELLP syndrome. Akusherstvo Ginekol 1996;35:14-14.

67.

67. Yao T , Yao H , Wang H . Diagnosis and treatment of nephrotic syndrome during pregnancy. Chinese Med J 1996; 109:471-471.

68.

68. Bonnar J , McNicol GP , Douglas AS . Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J 1971;1:12-12.

69.

69. Schjetlein R , Haugen G , Wisloff F . Markers of intravascular coagulation and fibrinolysis in preeclampsia: Association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997;76:541-541.

70.

70. Verduzco Rodriguez L , Gonzalez Puebla E , Manffrini Madrid F , Lopez Ariza B . D-dimer in different stages of pregnancy toxemia. A pilot study. Ginecol Obstet Mexico 1998;66:77-77.

71.

71. Ishibashi M , Ito N , Fujita M , et al. Endothelin-1 as an aggrevating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 1994;73: 191-191.

72.

72. Jones SL . HELLP: A cry for laboratory assistance: A comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol Mol Hematol 1998;11: 147-147.

73.

73. Cincotta R , Ross A . A review of eclampsia in Melbourne: 1978-1992. Aust NZ J Obstet Gynaecol 1996;36:264-264.

74.

74. D'Anna R . The HELLP syndrome. Notes on its pathogenesis and treatment. Min Ginecol 1996;48:147-147.

75.

75. Portis R , Jacobs MA , Skerman JH , Skerman EB . HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) pathophysiology and anesthetic considerations. AANA J 1997;65:37-37.

76.

76. Stone JH . HELLP syndrome: Hemolysis, elevated liver enzymes, and low platelets. JAMA 1998;280:559-559.

77.

77. Debette M , Samuel D , Ichai P , et al. Labor complications of the HELLP syndrome without any predictive factors. Gastroenterol Clin Biol 1999;23:264-264.

78.

78. Paternoster DM , Rodi J , Santarossa C , et al. Acute pancreatitis and deep vein thrombosis associated with the HELLP syndrome. Min Ginecol 1999;51:31-31.

79.

79. Sheikh RA , Yasmeen S , Pauly MP , Riegler JL . Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: Four cases and a review. J Clin Gastroenterol 1999;28:323-323.

80.

80. Weemhoff RA , van Loon AJ , Aarnoudse JG . Liver rupture in pregnancy: A life-threatening complication of the HELLP syndrome. Nederlands Tijdschr Geneesk 1996;140:2140-2140.

81.

81. Magann EF , Martin JN . Twelve steps to optimal managment of HELLP syndrome. Clin Obstet Gynecol 1999;42: 532-532.

82.

82. O'Boyle JD , Magann EF , Waxman E , Martin JN . Dexamethasone-facilitated postponement of delivery of an extremely preterm pregnancy complicated by the syndrome of hemolysis, elevated liver enzymes, and low platelets. Military Med 1999; 164:316-316.

83.

83. Vigil-De Gracia P , Garcia-Caceres E . Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynaecol Obstet 1997;59:217-217.

84.

84. Yalcin OT , Sener T , Hassa H , et al. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet 1998;61:141-141.

85.

85. Hamada S , Takishita Y , Tamura T , et al. Plasma exchange in a patient with postpartum HELLP syndrome. J Obstet Gynaecol Res 1996;22:371-371.

86.

86. Owen CA , Bowie EJW , Cooper HA . Turnover of fibrinogen and platelets in dogs undergoing induced intravascular coagulation. Thromb Res 1973;2:251-251.

87.

87. Rath W . Aggressive versus conservative management of HELLP syndrome-a status assessment. Geburtshilfe Frauenheilk 1996;56:265-265.

88.

88. Spivack JL , Sprangler DB , Bell WR . Defibrination after intra-amniotic injection of hypertonic saline. N Engl J Med 1972;287:321-321.

89.

89. Bick RL . Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management. Semin Thromb Hemost 1978;5:1-1.

90.

90. Bick RL . Alterations of hemostasis associated with malignancy. In: Murano G , Bick RL (eds). Basic Concepts of Hemostasis and Thrombosis. Boca Raton, FL: CRC Press, 1980:213-213.

91.

91. Bick RL . Alerations of hemostasis in malignancy. In: Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Chicago: ASCP Press, 1992:239-239.

92.

92. Bick RL , Strauss JF , Rutherford CJ , Frenkel E . Thrombosis and hemorrhage in oncology patients. Hematol Oncol Clin North Am 1996;10:875-875.

93.

93. Cafagna D , Ponte E . Pulmonary embolism of paraneoplastic origin. Min Med 1997;88:523-523.

94.

94. Frenkel UP , Bick RL . Issues of thrombosis and hemorrhagic events in patients with cancer. Anticancer Res 1998;18:1-1.

95.

95. Bick RL . Coagulation abnormalities in malignancy. Semin Thromb Hemost 1992;18:353-353.

96.

96. Bick RL . Disseminated intravascular coagulation. Hematol Oncol Clin North Am 1992;6: 1259-1259.

97.

97. Bick RL . Disseminated intravascular coagulation: A clinical review. Sem Thromb Hemost 1988;14:299-299.

98.

98. Bick RL , Kunkel L . Disseminated intravascular coagulation. Int J Hematol 1992;55: 1-1.

99.

99. Bick RL , Scates S . Disseminated intravascular coagulation. Lab Med 1992;23:161-161.

100.

100. Bick RL . Disseminated intravascular coagulation and related syndromes. A review. AM J Hematol 1978;5:265-265.

101.

101. Bick RL . Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology: Objective criteria for diagnosis and management. Hematol Oncol Clin North Am 2000;14:999-999.

102.

102. Goodnight SH . Bleeding and intravascular clotting in malignancy: A review. Ann NYAcad Sci 1974;230:271-271.

103.

103. Gralnick HR , Tan HK . Acute promyelocytic leukemia. A model for understanding the role of the malignant cells in hemostasis. Human Pathol 1974;5:661-661.

104.

104. Leavy RA , Kahn SB , Brodsky I . Disseminated intravascular coagulation: A complication of chemotherapy in acute promyelocytic leukemia. Cancer 1970;26:142-142.

105.

105. Pineo GF , Brain MC , Gallus AS . Tumors, mucus production, and hypercoagulability. Ann NY Acad Sci 1974;230:262-262.

106.

106. Pineo GF , Regorczi F , Hatton MWC . The activation of coagulation by extracts of mucin: A possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med 1973;82:255-255.

107.

107. Bick RL . Basic mechanisms of hemostasis pertaining to DIC. In: Disseminated Intravascular Coagulation and Related Syndromes. Boca Raton, FL: CRC Press, 1983:1-1.

108.

108. Bick RL . Disseminated intravascular coagulation and related syndromes. In: Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Chicago: ASCP Press, 1992:137-137.

109.

109. Piffare R . Pathology of Hemostasis in Cardiac Surgery and Cardiovascular Prosthetic Devices. In: Anticoagulants in Cardiac Medicine. Belfus Press, 1996.

110.

110. Lerner RG , Nelson JC , Corines P . del Guercio LRM . Disseminated intravascular coagulation: Complication of LeVeen peritoneovenous shunts. JAMA 1984;240:2064-2064.

111.

111. Stein SF , Fulenwider JT , Ansley JD . Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med 1981;141:1149-1149.

112.

112. Bick RL , Tse N . Hemostasis abnormalities associated with prosthetic devices and organ transplantation. Lab Med 1992;23:462-462.

113.

113. Bick RL . Disseminated intravascular coagulation and related syndromes: A clinical review. Sem Thromb Hemost 1988;14:299-299.

114.

114. Bick RL , WF Baker . Disseminated intavascular coagulation. Hematol Pathol 1992;6: 1-1.

115.

115. Egeberg O . Blood coagulation and intravascular hemolysis.Scand J Clin Lab Invest 1962;14:217-271.

116.

116. Krevins JR , Jackson DP , Cowley CL , Hartman RC . The nature of the hemorrhagic disorder accompanying hemolytic transfusion reactions in man. Blood 1957;12:834-834.

117.

117. Langdell RD , Hedgpeth EM . A study of the role of hemolysis in the hemostatic defect of transfusion reactions. Thromb Diath Haemorrh 1959;3:566-566.

118.

118. Surgenor DM . Erythrocytes and blood coagulation. Thromb Diath Haemorrh 1974;32:247-247.

119.

119. Abildgaard CF , Corrigan JJ , Seeler RA , et al. Meningiococcemia associated with intravascular coagulation. Pediatrics 1967;40:78-78.

120.

120. McKay DG , Muller-Berghous . Therapeutic implications if disseminated intravascular coagulation. AM J Cardiol 1967;20:392-392.

121.

121. Corrigan JJ . Changes in the blood coagulation system associated with septicemia. N Engl J Med 1968;279:851-851.

122.

122. Yoshikawa T , Tanaka R , Guze LB . Infection and disseminated intravascular coagulation. Medicine (Baltimore) 1971;50:237-237.

123.

123. Cline MJ , Melmon KL , Davis WC , Williams HE . Mechanism of endotoxin interaction with leukocytes.Br JHaematol 1968;15:539-539.

124.

124. McKay DG , Shapiro SS . Alterations in the blood coagulation system induced by bacterial endotoxin I: In vitro (generalized Schwartzman reaction). J Exp Med 1958;107:353-353.

125.

125. Baker WF . Clinical aspects of disseminated intravascular coagulation: A clinicians point of view. Sem Thromb Hemostas 1989;15:1-1.

126.

126. Bick RL . Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment and assessment of therapeutic response. Sem Thromb Hemost 1996;22:69-69.

127.

127. Cronberg S , Skansberg P , Nivenios-Larsson K . Disseminated intravascular coagulation in septicemia caused by beta-hemolytic streptococci. Thromb Res 1973;3:405-405.

128.

128. Rubenberg WL , Baker LR , McBride JA , et al. Intravascular coagulation in a case of clostridium perfringens septicemia: Treatment by exchange transfusion and heparin. Br Med J 1967;3:271-271.

129.

129. Bick RL . Disseminated intravascular coagulation: Objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clin Appl Thromb Hemost 1995;1:3-3.

130.

130. Gagel C , Linder M , Muller-Berghous G , Lasch H . Virus infection and blood coagulation. Thromb Diath Haemorrh 1970;23: 1-1.

131.

131. McKay DG , Margaretten W . Disseminted intravascular coagulation in virus diseases. Arch Intern Med 1967; 120:129-129.

132.

132. Salmon SJ , Lambert PH , Louis J . Pathogenesis of the intravascular coagulation syndrome induced by immunological reactions. Thromb Diath Haemorrh 1971;45:161-161.

133.

133. Bick RL . Hemostasis in malignancy. In: Bick RL (ed). Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Chicago: ASCP Press, 1992:239-239.

134.

134. Bick RL . Coagulation abnormalities in malignancy. Sem Thromb Hemost 1992;18:353-353.

135.

135. Bick RL . Alterations of hemostasis in malignancy. In: Bick RL , Bennett JM , Brynes RK (eds). Hematology: Clinical and Laboratory Practice. St Louis: Mosby, 1993:1583-1583.

136.

136. Brown RC , Campbell D , Thompson J . Increased fibrinolysis with malignant disease. Arch Intern Med 1962; 109:128-128.

137.

137. Silverstein MH . Agnogenic myeloid metaplasia. Action, MA: Publishing Sciences Group, 1975:10-10.

138.

138. Mersky C . Altered blood coagulability in patients with malignant tumors. Ann NYAcad Sci 1974;23:289-289.

139.

139. Hartman RC , Jenkins DE . Proxysmal nocturnal hemoglobinuria: Current concepts of certain pathophysiological features. Blood 1965;25:850-850.

140.

140. Bouchama A , Hammami M , Haq A , et al. Evidence for endothelial cell activation/injury in heatstroke. Crit Care Med 1996;24:1173-1173.

141.

141. Tang GJ . Similarity and synergy of trauma and sepsis: Role of tumor necrosis factor-alpha and interleukin-6. Acta Anaesthes Sin 1996;34:141-141.

142.

142. Gando S , Kameue T , Nanzaki S , et al. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Thromb Res 1995;80:519-519.

143.

143. Holder LA , Malin LL , Fox CL . Hypercoagulability after thermal injuries. Surgery 1963;54:316-316.

144.

144. Saliba MJ , Demsey WL , Kruggel JL . Large burns in humans: Treatment with heparin. JAMA 1973;225:261-261.

145.

145. Al-Mondhiry H . Disseminated intravascular coagulation: Experience in a major cancer center. Thromb Diath Haemorrh 1975;34:181-181.

146.

146. Aoki N , Moroi M , Matsuda M . The behavior of alpha-2-plasmin inhibitor in fibrinolytic states. J Clin Invest 1977;60:361-361.

147.

147. Olson JD , Kaufman H , Moake J , et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 1989;24:825-825.

148.

148. Touho H , Hirakawa K , Hino A , et al. Relationship between abnormalities of coagulation and fibrinolysis and postoperative intracranial hemorrhage in head injury. Neurosurgery 1986;19:523-523.

149.

149. Bick RL . Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation: A new clinical syndrome. In: Walz DA, McCoy LE (eds): Contributions to Hemostasis. Ann NYAcad Sci 1981;370:851-851.

150.

150. Inceman S , Tangun Y . Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia. Am J Med 1969;46:997-997.

151.

151. Kasabach HH , Merritt KK . Capillary hemangioma with extensive purpura-report of a case. Am J Dis Child 1940;59:1063-1063.

152.

152. Kaxmier FJ , Didisheim P , Fairbanks VK , Ludwig J , et al. Intravascular coagulation and arterial disease. Thromb Diath Haemorrh (suppl) 1969;36:295-295.

153.

153. Schnetzer GW , Penner JA . Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm. South Med J 1973;66:264-264.

154.

154. Owen CA , Bowie EJW . Chronic intravascular coagulation fibrinolysis (ICF) syndromes (DIC). Sem Thromb Hemost 1977;3:268-268.

155.

155. Bick RL , Tse N . Hemostasis abnormalities associated with prosthetic devices and organ transplantation. Lab Med 1992;23:462-462.

156.

156. Bick RL . Alterations of hemostasis associated with surgery, cardiopulmonary bypass surgery, and prosthetic devices. In: Ratnoff OD , Forbes C (eds). Disorders of Hemostasis. Philadelphia: WB Saunders, 1991:382-382.

157.

157. Bick RL . Disseminated intravascular coagulation. Hematol Oncol Clin North Am 1992;6:1259-1259.

158.

158. Muller-Berghaus G . Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anticoagulant pathways. Sem Thromb Hemost 1989;15:58-58.

159.

159. Mammen EF . Perspectives for the future. Intens Care Med (suppl) 1993;1:s29-s29.

160.

160. McKay DG , Margaretten W , Csavossy I . An electron microscope study of the effects of bacterial endotoxin on the blood-vascular system. Lab Invest 1966;15:1815-1815.

161.

161. Owen CA , Bowie EJW , Cooper HA . Turnover of fibrinogen and platelets in dogs undergoing induced intravascular coagulation. Thromb Res 1973;2:251-251.

162.

162. Latallo ZS . Products of fibrin(ogen) proteolysis. Thromb Diath Haemorrh (suppl) 1973;24:145-145.

163.

163. Marder VJ , Shulman HR , Carroll WR . High molecular weight derivitives of human fibrinogen produced by plasmin. I. Physico-chemical and immunological characterization. J Biol Chem 1969;244:2111-2111.

164.

164. Marder VJ , Budzynski AZ , James HL . High molecular weight derivitives of human fibrinogen produced by plasmin. III. Their NH2-terminal amino acids and comparison of the NH2-terminal amino disulfide knot. J Biol Chem 1972;247:4775-4775.

165.

165. Bang NU , Chang M . Soluble fibrin complexes. Sem Thromb Hemost 1974;1:91-91.

166.

166. Breen FA , Tullis JZ . Ethanol gelation, a rapid screening test for intravascular coagulation. Ann Intern Med 1968;69:111-111.

167.

167. Fletcher AP , Alkjaersig N , Fisher S , Sherry S . The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally. J Lab Clin Med 1966;68:780-780.

168.

168. Gurewich V , Hutchinson E . Detection of intravascular coagulation by protamine sulfate and ethanol gelation tests. Thromb Res 1973;2:539-539.

169.

169. Bick RL . The clinical significance of fibrinogen degradation products. Sem Thromb Hemost 1982;8:302-302.

170.

170. Kopec M , Wegrzynowiczy Z , Budzynski A , et al. Interaction of fibrinogen degradation products with platelets. Exp Biol Med 1968;3:73-73.

171.

171. Niewiarowski S , Regoeczi E , Stewart G , et al. Platelet interaction with polymerizing fibrin. J Clin Invest 1972;51:685-685.

172.

172. Robson S , Shephard E , Kirsch R . Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 1994;86:322-322.

173.

173. Okajima K , Uchiba M , Murakami K , et al. Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulation. Am J Hematol 1997;54:219-219.

174.

174. Ishibashi M , Ito N , Fujita M , et al. Endothelin-1 as an aggrevating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 1994;73:191-191.

175.

175. Ono S , Mochizuki H , Tamakuma S . A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am J Surg 1996;171:409-409.

176.

176. Elsayed Y , Nakagawa K , Ichikawa K , et al. Expression of tissue factor and interleukin-1 beta in a novel rabbit model of disseminated intravascular coagulation induced by carrageenan and lipopolysaccharide. Pathobiology 1995;63:328-328.

177.

177. Hoffman M , Cooper ST . Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 by two distinct mechanisms. Blood Cells Mol Dis 1995;21:156-156.

178.

178. Okajima K , Fujise R , Motosato Y , et al. Plasma levels of granulocyte elastase-alpha 1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: Pathophysiologic implications. Am J Hematol 1994;47:82-82.

179.

179. Nilsson IM . Local fibrinolysis as a mechanism for haemorrhage. Thromb Diath Haemorh 1975;34:623-623.

180.

180. Stormorken H . Relation of the fibrinolytic to other biological systems. Thromb Diath Haemorrh 1975;34:378-378.

181.

181. Schreiber AD , Austen KF . Interrelationships of the fibrinolytic, coagulation, kinin generation, and complement systems. Sem Hematol 1973;6:593-593.

182.

182. Collins P , Noble K , Reittie J , et al. Induction of tumor factor expression in human monocyte/endothelium cocultures. Br J Haematol 1995;91:963-963.

183.

183. Gando S , Nakanishi Y , Tedo I . Cytokines and plasminogen activator inhibitor-i in post-trauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction. Crit Care Med 1995;23:1835-1835.

184.

184. Kaplan A , Meier H , Mandel R . The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin generation. Sem Thromb Hemost 1976;3:6-6.

185.

185. Bick RL , Murano G . Physiology of hemostasis. In: Bick RL , Bennett JM , Brynes RK (eds). Hematology: Clinical and Laboratory Practice. St Louis: Mosby, 1993:1285-1285.

186.

186. van Iwaarden F , Bouma B . Role of high molecular weight kininogen in contact activation. Sem Thromb Hemost 1987;13:15-15.

187.

187. Beller FK , Theiss W . Fibrin derivitives, plasma hemoglobin and glomerular fibrin deposition in experimental intra-vascular coagulation. Thromb Diath Haemorrh 1973;29:363-363.

188.

188. McKay DG , Linder MM , Cruse VK . Mechanisms of thrombosis of the microcirculation. Am J Pathol 1971;63:231-231.

189.

189. Lerner RG . The defibrination syndrome. Med Clin North Am 1976;60:871-871.

190.

190. Robboy SJ , Coleman RW , Minna JD . Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases. Hum Pathol 1972;3:327-327.

191.

191. Muller-Berghous G . Pathophysiology of generalized intravascular coagulation. Sem Thromb Hemost 1977;3:209-209.

192.

192. Owen CA , Bowie EJW . Chronic Intravascular Syndromes. Mayo Clin Proc 1974;49:673-673.

193.

193. Bleyl U . Morphologic diagnosis of disseminated intravascular coagulation: Histologic, histochemical, and electron-microscopic studies. Sem Thromb Hemost 1977;3: 247-247.

194.

194. Skjorten F . Hyaline microthrombi in an autopsy material. A quantitative study with discussion of the relationship to small vessel thrombosis. Acta Pathol Microbiol Scand 1969;76:361-361.

195.

195. Morris JA , Smith RW , Assali NS . Hemodynamic action of vaso-pressor and vaso-depressor agents in endotoxin shock. Am J Obstet Gynecol 1965;91:491-491.

196.

196. Bleyl U , Kuhn W , Graeff H . Reticulo-endotheliale clearance intravascaler. Fibrinmonere in der milz. Thromb Diath Haemorrh 1969;22:87-87.

197.

197. Boyd JF . Disseminated fibrin-thromboembolism among neonates dying within 48 hours of birth. Arch Dis Child 1967;42:401-401.

198.

198. Bull B , Kuhn IN . The production of schistocytes by fibrin strands (a scanning electron microscope study). Blood 1970;35:104-104.

199.

199. Heyes H , Kohle W , Slijerpcevic B . The appearance of schistocytes in the peripheral blood in correlation to degree of disseminated intravascular coagulation. Haemostasis 1976;5:66-66.

200.

200. Bull B , Rubenberg M , Dacie J , Brain MC . Microangiopathic hemolytic anemia: Mechanisms of red-cell fragmentation. Br J Haematol 1968; 14:643-643.

201.

201. Slaastad RA , Godal NC . Coagulation profile and ethanol gelation test with special reference to components consumed during coagulation. Scand J Haematol 1976; 16:25-25.

202.

202. Bull B , Kuhn IN . The production of schistocytes by fibrin strands (a scanning electron microscope study). Blood 1970;35:104-104.

203.

203. Heyes H , Kohle W , Slijerpcevic B . The appearance of schistocytes in the peripheral blood in correlation to degree of disseminated intravascular coagulation. Haemostasis 1976;5:66-66.

204.

204. Bull B , Rubenberg M , Dacie J , Brain MC . Microangiopathic hemolytic anemia: Mechanisms of red-cell fragmentation. Br J Haematol 1968;14:643-643.

205.

205. Slaastad RA , Godal NC . Coagulation profile and ethanol gelation test with special reference to components consumed during coagulation. Scand J Haematol 1976; 16:25-25.

206.

206. Bick RL . Platelet defects. In: Disorders of Hemostasis and Thrombosis: Principles of Clinical Practice. Thieme, New York: 1985:65-65.

207.

207. Karpatkin S . Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978;51:307-307.

208.

208. Eckhardt T , Muller-Berghous G . The role of blood platelets in the precipitation of soluble fibrin endotoxin. Scand J Haematol 1975;14:181-181.

209.

209. Bick RL . The clinical significance of fibrinogen degradation products. Sem Thromb Hemost 1982;8:302-302.

210.

210. Blaisdell FW , Stallone RJ . The mechanism of pulmonary damage following traumatic shock. Surg Gynecol Obstet 1970;130:15-15.

211.

211. Bleyl U . Comparative studies in adults and newborn infants on the pathogenesis of pulmonary hyaline membranes. Verhandlungen Deutschen Gesellsch Pathol 1970;54:340-340.

212.

212. Martin AM , Soloway HB , Simmons RL . Pathologic anatomy of the lungs following shock and trauma. J Trauma 1968;8:687-687.

213.

213. Soloway HB , Castillo Y , Martin AM . Adult hyaline membrane disease. Ann Surg 1968;168:937-937.

214.

214. Hardaway RM , Adams WH . Blood clotting problems in acute care. Acute Care 1989;14/15:138-138.

215.

215. Hardaway RM , Dixon RS , Foster EF , et al. The effect of hemorrhagic shock on disseminated intravascular coagulation. Ann Surg 1976;184:43-43.

216.

216. Muller-Berghous G , Mann B . Precipitation of ancrod-induced soluble fibrin by aprotinin and norepinephrine. Thromb Res 1973;2:305-305.

217.

217. Bick RL . Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment and assessment of therapeutic response. Sem Thromb Hemost 1996;22:69-69.

218.

218. Bick RL . Clinical hemostasis practice: The major impact of laboratory automation. Sem Thromb Hemost 1983;9:139-139.

219.

219. Fareed J . New methods in hemostatic testing. In: Fareed J , Messmore HL , Fenton J , Brinkhous KM (eds). Perspectives in Hemostasis. New York: Pergamon Press, 1981:310-310.

220.

220. Messmore HL . Automation in coagulation testing: Clinical applications. Sem Thromb Hemost 1983;9:335-335.

221.

221. Bick RL . Disseminated intravascular coagulation: Clinical/laboratory correlations. Am J Clin Pathol 1982;77:244-244.

222.

222. Bick RL . Disseminated intravascular coagulation: Objective laboratory diagnostic criteria and guidelines for management. Clin Lab Med 1994;14:729-729.

223.

223. Marder VJ , Matchett MO , Sherry S . Detection of serum fibrinogen and fibrin degradation products: Comparison of six techniques using purified products and application in clinical studies. Am J Med 1971;51:71-71.

224.

224. Thomas DP , Niewiarowski S , Myers AR , et al. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med 1970;283:663-663.

225.

225. Bick RL . Disseminated intravascular coagulation and related syndromes. In: Bick RL , Bennett, Brynes , et al (eds). Hematology: Clinical and Laboratory Practice. St. Louis: Mosby, 1993.

226.

226. Gurewich V , Lipinsky B . Semiquantitative determination of soluble fibrin monomer complexes by chromatography and serial dilution protamine sulfate test. Am J Clin Pathol 1976;65:397-397.

227.

227. Hedner U , Nilsson IM . Parallel determinations of FDP and fibrin monomers with various methods. Thromb Diath Haemorrh 1972;28:268-268.

228.

228. Sonnabend D , Cooper D , Fiddes P , Penny R . Fibrin degradation products in thromboembolic disease. Pathology 1972;4:47-47.

229.

229. Stibbe J , Gomes M , de Ouda A . Management of chronic CID: Evaluation of separate measurements of fibrin (FbDP) and fibrinogen (FgDP) degradation products concomitant with fibrin monomers. Thromb Haemost 1989;62 (suppl 1) 373-373.

230.

230. Francis CW , Marder VJ . A molecular model of plasmic degradation of cross-linked fibrin. Sem Thromb Hemost 1982;8:25-25.

231.

231. Plow EF , Edgington TS . Surface markers of fibrinogen andits physiologic derivatives related by antibody probes. Sem Thromb Hemost 1982;8:36-36.

232.

232. Matsumoto T , Nishijima Y , Teramura Y , et al. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain. Thromb Res 1985;38:297-297.

233.

233. Rylatt DB , Blake AS , Cottis LE , et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983;31:767-767.

234.

234. Bick RL . Disseminated intravascular coagulation. In: Brubaker DB , Simpson MB (eds). Dynamics of Hemostasis and Thrombosis. Bethesda, MD: American Association of Blood Banks (AABB), 1995:133-133.

235.

235. Bick RL , Baker W . Diagnostic efficacy of the D-dimer assay in DIC and related disorders. Thromb Res 1992;65:785-785.

236.

236. Lane DA , Preston FE , Van Ross ME , Kakkar W . Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Br J Haematol 1978;40:609-609.

237.

237. Elms MJ , Bunce IH , Bundesen PG , et al. Measurement of cross-linked fibrin degradation products-an immunoassay using monoclonal antibodies. Thromb Haemost 1983;50:591-591.

238.

238. Ellis DR , Eaton AS , Plank MC , et al. A comparative evaluation of ELISA's for D-dimer and related fibrin(ogen) degradation products. Blood Coag Fibrinolysis 1993;4:537-537.

239.

239. Elias A , Aptel I , Huc B , et al. D-dimer test and diagnosis of deep vein thrombosis: A comparative study of 7 assays. Thromb Haemost 1996;76:518-518.

240.

240. Charles L , Edwards T , Macik B . Evaluation of sensitivity and specificity of six D-dimer latexc assays. Arch Pathol Lab Med 1994;118:1102-1102.

241.

241. Murano G . The molecular structure of fibrinogen. Sem Thromb Hemost 1974; 1:1-1.

242.

242. Rosenberg JS , Beeler DL , Rosenberg RD . Activation of human prothrombin by highly purified human factors V and Xa in the presence of human antithrombin. J Biol Chem 1975;250:1607-1607.

243.

243. Tietel JM , Bauer KA , Lau HK , Rosenberg RD . Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 +2 fragment and thrombin-antithrombin complex. Blood 1982;59:1086-1086.

244.

244. Boneu B , Bes G , Pelzer H , et al. D-dimers, thrombin antithrombin complexes and prothrombin fragments 1+2: Diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 1991;65:28-28.

245.

245. Bruhn HD , Conard J , Mannucci M , et al. Multicentric evaluation of a new assay for prothrombin fragment F 1+2 determination. Thromb Haemost 1992;68:413-413.

246.

246. Ceriello A , Giacomello R , Colatutto A , et al. Increased prothrombin fragment 1+2 in Type I diabetic patients. Haemostasis 1992;22:50-50.

247.

247. Demers C , Ginsberg JS , Henderson P , et al. Measurements of markers of activated coagulation in antithrombin III deficienct patients. Thromb Haemost 1992;67:542-542.

248.

248. Okamoto K , Takaki A , Takeda S , et al. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: Determination of prothrombin fragment 1+2 and other markers. Haemostasis 1992;22:17-17.

249.

249. Pelzer H , Schwarz A , Stuber W . Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991;65:153-153.

250.

250. Sorensen JV , Jensen HP , Rahr HR , et al. F 1+2 and FPA in urine from patients with multiple trauma and healthy individuals: A pilot study. Thromb Res 1992;67:429-429.

251.

251. Laurino JP , Pelletier TF , Eadry R , et al. Thrombus precursor protein and the measurement of thrombosis in patients with acute chest pain syndrome. Ann Clin Lab Sci 1997;27:338-338.

252.

252. Carville DG , Dimitrijevec N , Walsh M , et al. Thrombus precursor protein: Marker of thrombosis early in the pathogenesis of myocardial infarction. Clin Chem 1996;42:1537-1537.

253.

253. Bick RL , Dukes ML , Wilson WL , Fekete L . Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 1977;10:721-721.

254.

254. Bick RL . Clinical relevance of antithrombin III. Sem Thromb Hemost 1982;8:276-276.

255.

255. Okajima K . Clinical relevance of determination of plasma AT-III and alpha 2 PI activities in patientsd with DIC: Applications of the molecular markers for the pathophysiology of DIC. Jpn J Clin Pathol 1994;42:45-45.

256.

256. Bick RL , McClain BJ . A clinical comparison of chromogenic, fluorometric, and natural (fibrinogen) substrates for determination of antithrombin-III. Thromb Haemost 1981;46:364-364.

257.

257. Fareed J , Messmore HL , Walenga JM , et al. Laboratory evaluation of antithrombin III: A critical overview of currently available methods for antithrombin III measurements. Sem Thromb Hemost 1982;8:288-288.

258.

258. Asakura H , Saito M , Ito K , et al. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia. Thromb Res 1988;50:895-895.

259.

259. Cronlund M , Hardin J , Burton J , et al. Fibrinopeptide-A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosis. J Clin Invest 1976;58:142-142.

260.

260. Douglas JT , Shah M , Lowe GDO , Prentice CRM . Fibrinopeptide-A and Beta-thromboglobulin levels in preeclampsia and hypertensive pregnancy. Thromb Haemost 1982;47:54-54.

261.

261. Bauer KA , Weiss LM , Sparrow D , et al. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. J Clin Invest 1987;80:1527-1527.

262.

262. Walenga JM , Fareed J , Mariani G , et al. Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing thwe B beta 15-42 sequence. Sem Thromb Hemost 1984;10:252-252.

263.

263. Fareed J , Bick RL , Squillaci G , et al. Molecular markers of hemostatic disorders: Implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders. Clin Chem 1983;29:1641-1641.

264.

264. Harpel PC . Alpha-2-plasmin inhibitor and alpha-2-macroglobulin-plasmin complexes in plasma. J Clin Invest 1981;68:46-46.

265.

265. Clavin SA , Bobbitt JL , Shuman RT , Smithwick EL . Use of peptidyl-4-methoxy-2-naphthylamides to assay plasmin. Analy Biochem 1977;80:355-355.

266.

266. Banez EI , Triplett DA , Harms C . A clinical study on the use of a fluorogenic substrate assay of plasminogen. Thromb Res 1983;31:845-845.

267.

267. Menon IS , Martin A , Weightman D . Estimation of euglobulin lysis time using a time-saving recorder. Lab Pract 1969;18:1186-1186.

268.

268. Menon IS . A study of the possible correlation of euglobulin lysis time and dilute blood clot lysis time in the determination of fibrinolytic activity. Lab Pract 1968;17:334-334.

269.

269. Aoki N , Moroi M , Matsuda M . The behavior of alpha-2-plasmin inhibitor in fibrinolytic states. J Clin Invest 1977;60:361-361.

270.

270. Collen D , Wiman B . Turnover of antiplasmin, the fastacting plasmin inhibitor of plasma. Blood 0000;53:313-313.

271.

271. Bick RL , Murano G . Physiology of Hemostasis. Clin Lab Med 1994;14:677-677.

272.

272. Takahashi H , Koike T , Yoshida N , et al. Excessive fibrinolysis in suspected amyloidosis: Demonstration of plasmin-alpha-2 plasmin inhibitor complex and von Willebrand factor fragment in plasma. Am J Hematol 1986;23:153-153.

273.

273. Wiman B , Jacobsson L , Andersson M , Mellbring G . Determination of plasmin -alpha-2-plasmin inhibitor complex in plasma samples by means of a radioimmunoassay. Scand J Clin Lab Invest 1983;43:27-27.

274.

274. Takahashi H , Hanano M , Takizawa S , et al. Plasminalpha-2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation. Am J Hematol 1988;28:162-162.

275.

275. Matsuda T , Seki T , Ogawara M , et al. Levels of betathromboglobulin and platelet factor 4 in various diseases. Acta Hematol Japon 1980;43:871-871.

276.

276. Zahavi J , Kakkar W . B-thromboglobulin-a specific marker of in vivo platelet release reaction. Thromb Haemost 1980;44:23-23.

277.

277. Kwaan HC . Disseminated intravascular coagulation. Med Clin North Am 1972;56:177-177.

278.

278. Bick RL . Disseminated intravascular coagulation: Objective criteria for diagnosis and management. Med Clin North Am 1994; 78:511-511.

279.

279. Bick RL . Clinical implications of molecular markers in hemostasis and thrombosis. Sem Thromb Hemost 1984;10:290-290.

280.

280. Bick RL . Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations. Sem Thromb Hemost 1998;24:3-3.

281.

281. Feinstein DI . Treatment of disseminated intravascular coagulation. Sem Thromb Hemost 1988;14:351-351.

282.

282. Bick RL . Disseminated intravascular coagulation: A clinical/laboratory study of 48 patients. In: Walz D, McCoy L (eds). Contributions to Hemostasis. Ann NY Acad Sci 1981;370:843-843.

283.

283. Kuhn W , Graeft H . Gerinnungsstorungen in der Geburtshilfe. Stuttgart: Thieme Verlag, 1977:90-90.

284.

284. Minna JD , Robboy S , Coleman RW . Clinical aproach to a patient with suspected DIC. In: Minna JD , Robboy S , Coleman RW (eds). Disseminated Intravascular Coagulation. Springfield, IL: Charles C Thomas, 1974:167-167.

285.

285. Thaler E , Lechner K . Antithrombin III deficiency and thromboembolism. Clin Haematol 1981;10:369-369.

286.

286. Bentley PG , Kakkar WV , Scully MF , et al. An objectice study of alternative methods of heparin administration. Thromb Res 1980;18:177-177.

287.

287. Bick RL . Heparin therapy and monitoring: Guidelines and practice parameters for clinical and laboratory approaches. Clin Appl Thromb Hemost 1996;2:12-12.

288.

288. Markwardt F . Development of hirudin as an antithrombotic agent. Sem Thromb Hemost 1989;15:269-269.

289.

289. Fourrier F , Chopin C , Huart J , et al. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993;104:882-882.

290.

290. Talbot M . Biology of recombinant hirudin (CGP 39393): A new prospect in the treatment of thrombosis. Sem Thromb Hemost 1989;15:293-293.

291.

291. Niada R , Prota R , Pescador R , et al. Thrombolytic activity of defibrotide against old venous thrombi. Sem Thromb Hemost 1989;15:474-474.

292.

292. Ulutin ON . Clinical effectiveness of defibrotide in vasoocclusive disorders and its mode of action. Sem Thromb Hemost 1988;14:58-58.

293.

293. Umeki S , Adachi M , Watanabe M , et al. Gabexate as a therapy for disseminated intravascular coagulation. Arch Intern Med 1988;148:1409-1409.

294.

294. Abildgaard CF , Corrigan JJ , Seeler RA , et al. Meningiococcemia associated with intravascular coagulation. Pediatrics 1967;40:78-78.

295.

295. Bick RL , Schmalhorst WR , Fekete LF . Disseminated intravascular coagulation and blood component therapy. Transfusion 1976;16:361-361.

296.

296. Avvisati G , Buller HR , Wouter J , et al. Tranexamic acid for control of haemorrhage in acute promyelocytic leukemia. Lancet 1989;ii:122-122.

297.

297. Schwartz BS , Williams EC , Conlan MG , Mosher D . Epsilon-aminocaproic acid in the treatment of acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency. Ann Intern Med 1986;105:873-873.

298.

298. Patterson WP , Ringenberg QS . The pathophysiology of thrombosis in cancer. Sem Oncol 1990;17:140-140.

299.

299. Arkel YS . Thrombosis and cancer. Sem Oncol 2000; 27:362-362.